The creation of retatrutide, a novel dual agonist targeting both GLP-1 and GIP receptors, represents a complex several-stage chemical process. Preliminary routes focused on amino acid chain fragment coupling, utilizing https://mathefzoz696947.dm-blog.com/40987087/creation-and-investigation-implementations-of-retatrutide